Given the development of numerous approved immune checkpoint inhibitors, we attempted to evaluate PD-L1 immunohistochemical expression in HNSCC with a different clone, not so widely used, and determine its association with clinicopathological parameters. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.